(Q89603158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

review article

1 reference

title

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Eva Schrezenmeier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

publication date

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

6 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

155-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

6 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatolog

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

EULAR recommendations for the management of antiphospholipid syndrome in adults

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

New Treatment Guidelines for Sjögren's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Pregnancy and reproduction in autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis: A Randomized Trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Predictors of major infections in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Antimalarial drug discovery - approaches and progress towards new medicines.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Medical need, scientific opportunity and the drive for antimalarial drugs

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

CANDO and the infinite drug discovery frontier

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

High-level semi-synthetic production of the potent antimalarial artemisinin

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Natural products from synthetic biology

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Paths to a malaria vaccine illuminated by parasite genomics

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Antimalarial drug discovery: in silico structural biology and rational drug design.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Mobile phones and malaria: modeling human and parasite travel

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Big data opportunities for global infectious disease surveillance

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine in systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

4-aminoquinoline based molecular hybrids as antimalarials: an overview

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Synthesis and preliminary pharmacological evaluation of asymmetric chloroquine analogues

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Effects of chloroquine and its enantiomers on the development of rat embryos in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Bioavailability of hydroxychloroquine tablets in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Do some chronic pain patients with atypical facial pain overvalue and obsess about their pain?

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

CYP2C8 and antimalaria drug efficacy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Digoxin-hydroxychloroquine interaction?

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Influence of hydroxychloroquine on the bioavailability of oral metoprolol

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Retinal pigment epithelium cell culture as a model for evaluation of the toxicity of tamoxifen and chloroquine

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Antimalarial drugs in systemic lupus erythematosus: use in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Prevention and treatment in utero of autoimmune-associated congenital heart block

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Rheumatoid arthritis medications and lactation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Lysosomes as dynamic regulators of cell and organismal homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Intracellular transport of class II MHC molecules directed by invariant chain.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Autophagy in dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Autophagy Beyond Intracellular MHC Class II Antigen Presentation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The Cytosolic DNA Sensor cGAS Forms an Oligomeric Complex with DNA and Undergoes Switch-like Conformational Changes in the Activation Loop

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The mechanism of double-stranded DNA sensing through the cGAS-STING pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Cutting edge: Antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Therapeutic Targeting of Autophagy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

On the inhibitory effect of chloroquine on blood platelet aggregation

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Chloroquine inhibits stimulated platelets at the arachidonic acid pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Incidence of cancer in a cohort of patients with primary Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Severe hydroxychloroquine myopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine-induced autophagic vacuolar myopathy with mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine retinopathy - implications of research advances for rheumatology care

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Kinetics of chloroquine uptake into isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Hydroxychloroquine-induced mimic of renal Fabry disease

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Joint recommendations for retinal screening in long-term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Multifaceted roles of ATM in autophagy: From nonselective autophagy to selective autophagy

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FS41584-020-0372-X

7 January 2021

The accuracy of commercial calibration sera and assayed control sera

1 reference

12 December 2020

Variation of cell kinetic parameters in relation to the growth rate of the Ehrlich ascites tumor

1 reference

12 December 2020

The pressor response to central administration of beta-endorphin results from a centrally mediated increase in noradrenaline release and adrenaline secretion

1 reference

12 December 2020

To B, or not to B: that is the question

1 reference

12 December 2020

Legal implications of restraints

1 reference

12 December 2020

The effectiveness of dentine adhesives as demonstrated by dye penetration and SEM investigations

1 reference

12 December 2020

[Audit of clinical records: clinico-microbiologic study of urinary infections in a team of primary care]

1 reference

12 December 2020

Paralytic ileus, a serious complication in acute diarrhoea disease among infants in developing countries

1 reference

12 December 2020

Sirenomelia without Potter syndrome: MR characteristics.

1 reference

12 December 2020

Colloidal gold label observed with a high resolution backscattered electron imaging in mouse lymphocytes

1 reference

12 December 2020

Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials.

1 reference

12 December 2020

[Two-staged operation of dissecting aneurysm of the thoraco-abdominal aorta complicating with saccular aneurysm]

1 reference

12 December 2020

[Localization of small subcortical processes in important functional zones by preoperative x-ray computed tomography]

1 reference

12 December 2020

Tetra-t-butoxydisiloxane-1,3-diyl, a new type of bifunctional silyl protective group

1 reference

12 December 2020

The crystal structure of mercury-substituted poplar plastocyanin at 1.9-A resolution

1 reference

12 December 2020

The development of the vertebral column

1 reference

12 December 2020

Quality assurance under the Missouri PRO program

1 reference

12 December 2020

[The "paraproteins" of types Ig G and Ig A in subjects without Kahler's disease]

1 reference

12 December 2020

The physiology of teichoic acid deficient staphylococci

1 reference

12 December 2020

The effect of thyroxine and triiodothyronine on bacterial growth

1 reference

12 December 2020

Solitary mastocytoma of infancy

1 reference

12 December 2020

Monitoring the effectiveness of antimicrobial agents in a general hospital

1 reference

12 December 2020

The effect of steroids on the transport of electrolytes through membranes

1 reference

12 December 2020

Interactions of polyoma and mouse DNAs. I. Lytic infection of bromodeoxyuridine-prelabeled mouse embryo cells

1 reference

12 December 2020

Ultrastructure of uveal melanoma cells in cell cultures

1 reference

12 December 2020

Jejunojejunal intussusception. An unusual complication after pancreatoduodenectomy

1 reference

12 December 2020

Some comments on the failure of behavior therapy as a technique for modifying cigarette smoking

1 reference

12 December 2020

Electric power supply, electric lighting and protective measures against explosions in operating rooms

1 reference

12 December 2020

Influence of toxic doses of ouabain on catecholamine levels in dogs

1 reference

12 December 2020

Age and Dose Dependence of Bone Growth Retardation Induced by X-Irradiation

1 reference

12 December 2020

Role-playing theory vs. clinical psychiatry

1 reference

12 December 2020

Content of fluorides in running water supplied to schools and nurseries in the Szczecin province

1 reference

12 December 2020

Enzymes of drug metabolism. Scientific session of the Société Française de Biologie Clinique. 30 November 1979

1 reference

12 December 2020

Thermodynamic nonideality as a probe of macromolecular isomerizations: Application to the acid expansion of bovine serum albumin

1 reference

12 December 2020

Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns

1 reference

12 December 2020

Effects of limited tryptic cleavage on the physical and enzymatic properties of myosin II from Acanthamoeba castellanii

1 reference

12 December 2020

[Behavior of blood gases under fiberbronchoscopy in premedication with flunitrazepam (Rohypnol)]

1 reference

12 December 2020

The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus

1 reference

12 December 2020

Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.

1 reference

12 December 2020

Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.

1 reference

12 December 2020

Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.

1 reference

12 December 2020

Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.

1 reference

12 December 2020

Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.

1 reference

12 December 2020

Hydroxychloroquine neuromyotoxicity

1 reference

12 December 2020

Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate

1 reference

12 December 2020

Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.

1 reference

12 December 2020

Malaria vaccine: a future hope to curtail the global malaria burden

1 reference

12 December 2020

No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine

1 reference

12 December 2020

10.1038/S41584-020-0372-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32034323%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference